ACAD
ACADIA Pharmaceuticals Inc
20.70$
-6.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | +844.3% | -30.4% | |
| – | +214.1% | +182.5% | +48.4% | +10.8% | -8.0% | +6.0% | +14.1% | -39.4% | +174.0% | +186.1% | -26.0% | |
| – | +150.6% | +37.5% | +36.7% | +8.0% | +0.9% | +2.6% | -24.6% | +7.2% | -2.6% | +0.9% | -22.2% | |
| – | +149.1% | +37.1% | +37.4% | +11.0% | -2.7% | +59.9% | -52.8% | +1.0% | – | – | – | |
| – | -55.8% | +6.8% | -245.9% | – | – | +197.9% | -324.9% | – | -52.3% | -77.1% | -2,260.2% | |
| – | +1,089.4% | +344.0% | -91.5% | +164.5% | -47.4% | +572.0% | -85.2% | -100.0% | – | -98.7% | +796.7% | |
| – | – | -277.5% | – | -177.3% | +132.0% | – | -136.9% | – | -56.3% | -195.4% | +890.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -93.0% | +3,540.1% | -94.0% | +883.2% | +21.3% | -78.2% | -77.6% | – | – | – | – | |
| – | -92.9% | +3,581.0% | -94.2% | +883.2% | +21.3% | -78.2% | -77.6% | -54.9% | +206.5% | -72.8% | +628.8% | |
| – | -19.7% | +52.6% | -253.2% | – | -18.9% | +150.2% | -230.0% | – | – | +81.5% | -205.9% | |
| – | – | – | – | – | – | – | – | – | – | – | -33.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.